Literature DB >> 18083801

Molecular characterization reveals similar virulence gene content in unrelated clonal groups of Escherichia coli of serogroup O174 (OX3).

Cheryl L Tarr1, Adam M Nelson, Lothar Beutin, Katharina E P Olsen, Thomas S Whittam.   

Abstract

Most severe illnesses that are attributed to Shiga toxin-producing Escherichia coli are caused by isolates that also carry a pathogenicity island called the locus of enterocyte effacement (LEE). However, many cases of severe disease are associated with LEE-negative strains. We characterized the virulence gene content and the evolutionary relationships of Escherichia coli isolates of serogroup O174 (formerly OX3), strains of which have been implicated in cases of hemorrhagic colitis and hemolytic uremic syndrome. A total of 56 isolates from humans, farm animals, and food were subjected to multilocus virulence gene profiling (MVGP), and a subset of 16 isolates was subjected to multilocus sequence analysis (MLSA). The MLSA revealed that the O174 isolates fall into four separate evolutionary clusters within the E. coli phylogeny and are related to a diverse array of clonal groups, including enteropathogenic E. coli 2 (EPEC 2), enterohemorrhagic E. coli 2 (EHEC 2), and EHEC-O121. Of the 15 genes that we surveyed with MVGP, only 6 are common in the O174 strains. The different clonal groups within the O174 serogroup appear to have independently acquired and maintained similar sets of genes that include the Shiga toxins (stx1 and stx2) and two adhesins (saa and iha). The absence of certain O island (OI) genes, such as those found on OI-122, is consistent with the notion that certain pathogenicity islands act cooperatively with the LEE island.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083801      PMCID: PMC2238209          DOI: 10.1128/JB.01317-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  35 in total

1.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G Plunkett; V Burland; B Mau; J D Glasner; D J Rose; G F Mayhew; P S Evans; J Gregor; H A Kirkpatrick; G Pósfai; J Hackett; S Klink; A Boutin; Y Shao; L Miller; E J Grotbeck; N W Davis; A Lim; E T Dimalanta; K D Potamousis; J Apodaca; T S Anantharaman; J Lin; G Yen; D C Schwartz; R A Welch; F R Blattner
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

2.  Identification of virulence genes linked with diarrhea due to atypical enteropathogenic Escherichia coli by DNA microarray analysis and PCR.

Authors:  Jan Egil Afset; Guillaume Bruant; Roland Brousseau; Josée Harel; Endre Anderssen; Lars Bevanger; Kåre Bergh
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

3.  A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages.

Authors:  H Karch; S Schubert; D Zhang; W Zhang; H Schmidt; T Olschläger; J Hacker
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.

Authors:  A W Paton; P Srimanote; M C Woodrow; J C Paton
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  toxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype.

Authors:  I Tatsuno; M Horie; H Abe; T Miki; K Makino; H Shinagawa; H Taguchi; S Kamiya; T Hayashi; C Sasakawa
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12.

Authors:  T Hayashi; K Makino; M Ohnishi; K Kurokawa; K Ishii; K Yokoyama; C G Han; E Ohtsubo; K Nakayama; T Murata; M Tanaka; T Tobe; T Iida; H Takami; T Honda; C Sasakawa; N Ogasawara; T Yasunaga; S Kuhara; T Shiba; M Hattori; H Shinagawa
Journal:  DNA Res       Date:  2001-02-28       Impact factor: 4.458

7.  Parallel evolution of virulence in pathogenic Escherichia coli.

Authors:  S D Reid; C J Herbelin; A C Bumbaugh; R K Selander; T S Whittam
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

8.  Two cases of human urinary tract infection complicated by hemolytic uremic syndrome caused by verotoxin-producing Escherichia coli.

Authors:  F Scheutz; B Olesen; A Nørgaard
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

9.  Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France.

Authors:  N Pradel; V Livrelli; C De Champs; J B Palcoux; A Reynaud; F Scheutz; J Sirot; B Joly; C Forestier
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

10.  Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa.

Authors:  Adrienne W Paton; James C Paton
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

View more
  3 in total

1.  Comparative genomics and stx phage characterization of LEE-negative Shiga toxin-producing Escherichia coli.

Authors:  Susan R Steyert; Jason W Sahl; Claire M Fraser; Louise D Teel; Flemming Scheutz; David A Rasko
Journal:  Front Cell Infect Microbiol       Date:  2012-11-07       Impact factor: 5.293

2.  Colonisation of Meat by Escherichia coli O157:H7: Investigating Bacterial Tropism with Respect to the Different Types of Skeletal Muscles, Subtypes of Myofibres, and Postmortem Time.

Authors:  Caroline Chagnot; Annie Venien; Sandra Renier; Nelly Caccia; Régine Talon; Thierry Astruc; Mickaël Desvaux
Journal:  Front Microbiol       Date:  2017-07-25       Impact factor: 5.640

3.  Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement.

Authors:  Hayley J Newton; Joan Sloan; Dieter M Bulach; Torsten Seemann; Cody C Allison; Marija Tauschek; Roy M Robins-Browne; James C Paton; Thomas S Whittam; Adrienne W Paton; Elizabeth L Hartland
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.